Literature DB >> 15483292

Bevacizumab in colorectal cancer.

Guru Sonpavde.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483292     DOI: 10.1056/NEJM200410143511622

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model.

Authors:  João Conde; Nuria Oliva; Yi Zhang; Natalie Artzi
Journal:  Nat Mater       Date:  2016-07-25       Impact factor: 43.841

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.